Kanada - angol - Health Canada

pharmascience inc - methotrexate (methotrexate sodium) - solution - 20mg - methotrexate (methotrexate sodium) 20mg

Kanada - angol - Health Canada

pharmascience inc - methotrexate (methotrexate sodium) - solution - 22.5mg - methotrexate (methotrexate sodium) 22.5mg

Kanada - angol - Health Canada

pharmascience inc - methotrexate (methotrexate sodium) - solution - 25mg - methotrexate (methotrexate sodium) 25mg

Kanada - angol - Health Canada

pharmascience inc - methotrexate (methotrexate sodium) - solution - 10mg - methotrexate (methotrexate sodium) 10mg

Kanada - angol - Health Canada

pharmascience inc - methotrexate (methotrexate sodium) - solution - 12.5mg - methotrexate (methotrexate sodium) 12.5mg

Egyesült Államok - angol - NLM (National Library of Medicine)

remedyrepack inc. - methotrexate sodium (unii: 3ig1e710zn) (methotrexate - unii:yl5fz2y5u1) - methotrexate is indicated in the treatment of gestational choriocarcinoma, chori-oadenoma destruens and hydatidiform mole. methotrexate is used in maintenance therapy in combination with other chemotherapeutic agents. methotrexate is used alone or in combination with other anticancer agents in the treatment of breast cancer, epidermoid cancers of the head and neck, advanced mycosis fungoides (cutaneous t cell lymphoma), and lung cancer, particularly squamous cell and small cell types. methotrexate is also used in combination with other chemotherapeutic agents in the treatment of advanced stage non-hodgkin's lymphomas. methotrexate is indicated in the symptomatic control of severe, recalcitrant, disabling psoriasis that is not adequately responsive to other forms of therapy, but only when the diagnosis has been established, as by biopsy and/or after dermatologic consultation . it is important to ensure that a psoriasis "flare" is not due to an undiagnosed concomitant disease affecting immune res

Kanada - angol - Health Canada

pharmascience inc - methotrexate (methotrexate disodium) - tablet - 2.5mg - methotrexate (methotrexate disodium) 2.5mg - antineoplastic agents

Kanada - angol - Health Canada

teva canada limited - methotrexate (methotrexate sodium) - solution - 25mg - methotrexate (methotrexate sodium) 25mg - antineoplastic agents

Egyesült Államok - angol - NLM (National Library of Medicine)

hospira, inc. - methotrexate sodium (unii: 3ig1e710zn) (methotrexate - unii:yl5fz2y5u1) - methotrexate 25 mg in 1 ml - methotrexate is indicated in the treatment of gestational choriocarcinoma, chorioadenoma destruens and hydatidiform mole. in acute lymphocytic leukemia, methotrexate is indicated in the prophylaxis of meningeal leukemia and is used in maintenance therapy in combination with other chemotherapeutic agents. methotrexate is also indicated in the treatment of meningeal leukemia. methotrexate is used alone or in combination with other anticancer agents in the treatment of breast cancer, epidermoid cancers of the head and neck, advanced mycosis fungoides (cutaneous t cell lymphoma), and lung cancer, particularly squamous cell and small cell types. methotrexate is also used in combination with other chemotherapeutic agents in the treatment of advanced stage non-hodgkin's lymphomas. methotrexate in high doses followed by leucovorin rescue in combination with other chemotherapeutic agents is effective in prolonging relapse-free survival in patients with non-metastatic osteosarcoma who have undergone surgical resection

Kanada - angol - Health Canada

pfizer canada ulc - methotrexate (methotrexate sodium) - solution - 25mg - methotrexate (methotrexate sodium) 25mg - antineoplastic agents